Myasthenia Gravis Plasma

About:Myasthenia Gravis Plasma - Cryopreserved human plasma from clinically confirmed myasthenia gravis donors. Ideal for profiling AChR and MuSK autoantibodies, complement proteins, and inflammatory cytokines, with AChR-positive, MuSK-positive, and seronegative donors available.

Typically ships in 2–3 business days

$495 / unit

SKU MYG-PLA

Size

QUANTITY

Format

Clear

Donor preference

No preference Unique donors Same donor

																							Specimen ID	Sample Type	Primary Disease	Diagnosis	Allergies	Allergy List	BMI	CMV Status	Has Infectious Disease	Infectious Disease	Tobacco Use	Years of Smoking	Packs per Day	Alcohol Use	Recreational Drug Use	Caffeine Use	ABO Type	Rh Type	Sample Status	Availability
Myasthenia Gravis Plasma	70899	152931	Female	61+	Asian/Pacific Islander	Frozen	1 mL	7	—	Escitalopram 10mg 1/day Mycophenolate Mofetil 250mg 4/day amlodipine 5mg 1/day Losartan 50mg 1/day	Myasthenia Gravis	United States	2025	11:01:01:01/26:01:01:01	—	—	—	—	—	—	—	—	168739; 168740; 168741; 168742; 168743; 168744; 168745	Plasma	Myasthenia Gravis	Myasthenia Gravis	No	Bee's	24.69	Reactive	No		No			Yes	NO	Yes	A	RH+	Stored	In Stock	$495
Myasthenia Gravis Plasma	77426	110012	Female	31-45	Caucasian	Frozen	1 mL	17	—	(IV infusion treatments- IVIG & Soliris: get at Ivx heath) IV bard power port needle 3/4ths Soliris IV 1200 mg: 1 day every other week Vvygart Infusion, weekly on Mondays x4 revaluating Tylenol (with IVIG and Soliris) Benadryl (with IVIG) IV Benadryl (with Soliris) Amitriptyline 10 mg: 4 at night Prednisone 10 mg: 5 in morning Emgality: once a month on the 9th. Calcium 600 mg plus D3 20 mcg: 1 in morning Folic acid: 1mg tablets B12 1000 mcg: 1 in morning --As Needed Meds-- Ubrelvy mg: as needed -Continuous Meds- Testosterone CYP 120 mg/ .6 ml subcutaneous: once every Wednesday Lamictal 200 mg ER: 1 in morning, 1 at night Ritalin 20 mg: 1 pill morning, 1 pill noon buspar 10 mg: 1 pill morning, 1 pill noon, 1 pill at night Lexapro 20 mg: 1 in morning Seroquel 100 mg er: 3 at night -As Needed Meds- Lorazepam 1 mg: as needed Hydroxyzine: as needed Amlodipine tab 10mg: 1 in morning Topamax 50 mg: 1 in morning, 1 at night Ropinirole HCL 3 mg: 1 at night BIPAP: Pressure 18 over 13 Famotidine 20 mg: 1 in morning, 1 at night --As Needed Meds-- Ondansetron ODT 4 mg: as needed Eye gel lubricant drops- 3 times a day Retin-A (tretinoin) cream 0.1%: at night every few days as tolerated where acne is Clindamycin Phosphate Topical solution USP, 1%: Put on back, chest and shoulders once in morning, once at night Finacea (azealic acid) Ventolin HFA 90 mcg per actuation: as needed Trimodal 50mg: as needed *Triamcinolone Acetonide ointment USP, 0.1%: as needed	Hidradenitis Suppurativa, Myasthenia Gravis	United States	2026	—	—	—	—	—	—	—	—	—	206201; 206198; 206206; 206194; 206205; 206202; 206200; 206197; 206199; 206196; 206193; 206192; 206191; 206190; 206204; 206195; 206203	Plasma	Myasthenia Gravis	Myasthenia Gravis;Hidradenitis Suppurativa	Yes	bactrim, monoset, nasonex	37.93		No		No			No	NO	No			Stored	In Stock	$495
Myasthenia Gravis Plasma	73627	110012	Female	31-45	Caucasian	Frozen	1 mL	17	—	(IV infusion treatments- IVIG & Soliris: get at Ivx heath) IV bard power port needle 3/4ths Soliris IV 1200 mg: 1 day every other week Vvygart Infusion, weekly on Mondays x4 revaluating Tylenol (with IVIG and Soliris) Benadryl (with IVIG) IV Benadryl (with Soliris) Amitriptyline 10 mg: 4 at night Prednisone 10 mg: 5 in morning Emgality: once a month on the 9th. Calcium 600 mg plus D3 20 mcg: 1 in morning Folic acid: 1mg tablets B12 1000 mcg: 1 in morning --As Needed Meds-- Ubrelvy mg: as needed -Continuous Meds- Testosterone CYP 120 mg/ .6 ml subcutaneous: once every Wednesday Lamictal 200 mg ER: 1 in morning, 1 at night Ritalin 20 mg: 1 pill morning, 1 pill noon buspar 10 mg: 1 pill morning, 1 pill noon, 1 pill at night Lexapro 20 mg: 1 in morning Seroquel 100 mg er: 3 at night -As Needed Meds- Lorazepam 1 mg: as needed Hydroxyzine: as needed Amlodipine tab 10mg: 1 in morning Topamax 50 mg: 1 in morning, 1 at night Ropinirole HCL 3 mg: 1 at night BIPAP: Pressure 18 over 13 Famotidine 20 mg: 1 in morning, 1 at night --As Needed Meds-- Ondansetron ODT 4 mg: as needed Eye gel lubricant drops- 3 times a day Retin-A (tretinoin) cream 0.1%: at night every few days as tolerated where acne is Clindamycin Phosphate Topical solution USP, 1%: Put on back, chest and shoulders once in morning, once at night Finacea (azealic acid) Ventolin HFA 90 mcg per actuation: as needed Trimodal 50mg: as needed *Triamcinolone Acetonide ointment USP, 0.1%: as needed	Myasthenia Gravis	United States	2026	—	—	—	—	—	—	—	—	—	190699; 190700; 190697; 190693; 190694; 190692; 190695; 190690; 190691; 190689; 190686; 190688; 190687; 190685; 190701; 190696; 190698	Plasma	Myasthenia Gravis	Myasthenia Gravis	Yes	bactrim, monoset, nasonex	37.93		No		No			No	NO	No			Stored	In Stock	$495
Myasthenia Gravis Plasma	73889	154108	Female	61+	Caucasian	Frozen	1 mL	8	—	Methotrexate Prednisone 2 rounds of Rystiggo -MG Calcium Folic Acid Lisinopril	Myasthenia Gravis	United States	2026	A23:01:01:01/A24:02:01:01	—	—	—	—	—	—	—	—	189758; 189756; 189755; 189757; 189754; 189752; 189753; 189751	Plasma	Myasthenia Gravis	Myasthenia Gravis	No		35.75	Non Reactive	Yes	Hepatitis C	No			Yes	NO	Yes	B	RH-	Stored	In Stock	$495
Myasthenia Gravis Plasma	73743	118698	Female	61+	Caucasian	Frozen	1 mL	16	—	Prednisone/10mg/QD Duloxetine Zolpidem/QPM Folic Acid Eliquis 5 mg BID Sulfasalazine Lamitrogine Metoprolol Ozempic History of: Mestinon/60mg/TID	Myasthenia Gravis	United States	2026	—	—	—	—	—	—	—	—	—	188905; 188900; 188904; 188897; 188898; 188911; 188908; 188903; 188912; 188906; 188902; 188901; 188910; 188909; 188899; 188907	Plasma	Myasthenia Gravis	Myasthenia Gravis	Yes	Morphine	30.68		No		No			No	NO	Yes			Stored	In Stock	$495
Myasthenia Gravis Plasma	73223	140846	Female	61+	Caucasian	Frozen	1 mL	17	—	Prednisone 20mg QD Leflunomide 20 mg QD Mestinon 60 mg 4x/day Albuterol inhaler Atorvastatin 40mg Vitamin B Biotin Epipen PRN Pepcid 20mg QD Lasix 20mg PRN Adderall XR QD Femidate 0.05% Gemteza 75 mg Plaquenil 200mg QD Meloxicam 15mg QD Lyrica 150mg BID Zofran 4mg PRN Q 8 Estradiol patch Meclizine – PRN Myrbetriq 1 mg QD IVIG infusions – Intravenous immune globulin (dose and schedule per doctor) Singulair 10 mg QD – once daily (montelukast, for allergies or asthma) Imitrex – PRN (sumatriptan, for migraines) Amovig inj monthly	Myasthenia Gravis	United States	2026	—	—	—	—	—	—	—	—	—	185452; 185453; 185454; 185455; 185456; 185464; 185457; 185465; 185458; 185466; 185459; 185467; 185460; 185468; 185461; 185462; 185463	Plasma	Myasthenia Gravis	Myasthenia Gravis	Yes	sulfa, ivp dye, bees, topical iodine	23.23		No										Stored	In Stock	$495
Myasthenia Gravis Plasma	70830	117854	Male	61+	Hispanic/Latino	Frozen	1 mL	12	—	Mestinon/60mg/TID Escitalopran/10mg/QD	Myasthenia Gravis	United States	2025	—	—	—	—	—	—	—	—	—	172907; 172908; 172909; 172910; 172911; 172912; 172913; 172914; 172915; 172916; 172917; 172918	Plasma	Myasthenia Gravis	Myasthenia Gravis	Yes	seasonal allergies	38.73		No		No			No	NO	Yes			Stored	In Stock	$495
Myasthenia Gravis Plasma	70862	150626	Female	18-30	Caucasian	Frozen	1 mL	12	—	Mestinon prednisone methotrexate omeprazole trazadone Adapalene facial topical gabapentin Gallifrey (birth control) Duloxetine Spiriva Celebrex Advair Iron - OTC Vitamin D3 Folic acid calcium	Myasthenia Gravis	United States	2025	—	—	—	—	—	—	—	—	—	171231; 171232; 171233; 171234; 171235; 171236; 171237; 171238; 171239; 171240; 171241; 171242	Plasma	Myasthenia Gravis	Myasthenia Gravis	Yes	Zoloft, Dust, pollen, polysporin	35.9		No		No			Yes	NO	Yes			Stored	In Stock	$495
Myasthenia Gravis Plasma	70794	135531	Male	61+	Caucasian	Frozen	1 mL	12	—	Guanfacine 0.5mg QPM Zoloft 25mg QD anxiety Ropinirole 0.5mg RLS	Myasthenia Gravis	United States	2025	—	—	—	—	—	—	—	—	—	169124; 169125; 169126; 169127; 169128; 169129; 169130; 169131; 169132; 169134; 169135; 169123	Plasma	Myasthenia Gravis	Myasthenia Gravis	No		37.86		No		No			No	NO	Yes			Stored	In Stock	$495
Myasthenia Gravis Plasma	66214	119744	Male	61+	Caucasian	Frozen	1 mL	10	—	Cellcept 500mg 3 times per day Mestinon 60mg 3 per times days Memantine 10g twice daily	Myasthenia Gravis	United States	2025	—	—	—	—	—	—	—	—	—	146025; 146026; 146027; 146028; 146029; 146030; 146021; 146022; 146023; 146024	Plasma	Myasthenia Gravis	Myasthenia Gravis	Yes	Seasonal, sulfa, codeine sulfate	22.96		No		No			Yes	NO	No			Stored	In Stock	$495
Myasthenia Gravis Plasma	66145	112296	Female	46-60	Caucasian	Frozen	1 mL	14	—	hizentra subcutaneous generic Ibuprofen/PRN - for migraines Mestinon/30-60mg/PRN (takes more if nothing happens) Xembify 30ml once weekly	Myasthenia Gravis	United States	2025	—	—	—	—	—	—	—	—	—	89378; 89379; 89381; 89382; 89384; 89385; 89386; 89387; 89388; 89389; 89390; 89391; 89392; 89393	Plasma	Myasthenia Gravis	Myasthenia Gravis	Yes	sticky tape	23.77		No		Used to Smoke	18	0.5	Yes	NO	Yes			Stored	In Stock	$495
Myasthenia Gravis Plasma	66202	110947	Male	61+	Caucasian	Frozen	1 mL	14	—	Mestinon/60mg/BID	Myasthenia Gravis	United States	2025	—	—	—	—	—	—	—	—	—	89362; 89363; 89364; 89365; 89366; 89367; 89368; 89369; 89370; 89371; 89372; 89373; 89374; 89375	Plasma	Myasthenia Gravis	Myasthenia Gravis	No		22.38		No		No			No	NO	Yes			Stored	In Stock	$495
Myasthenia Gravis Plasma	73547	148928	Female	46-60	Caucasian	Frozen	1 mL	13	—	Zilbrysq Rosuvastatin 40mg QD Buspirone 5Mg 3 times daily	Myasthenia Gravis	United States	2026	—	—	—	—	—	—	—	—	—	188516; 188517; 188518; 188519; 188520; 188521; 188509; 188510; 188511; 188512; 188513; 188514; 188515	Plasma	Myasthenia Gravis	Myasthenia Gravis	No		20.78		No		Used to Smoke	32		No	NO	Yes			Stored	In Stock	$495
Myasthenia Gravis Plasma	75192	125995	Male	61+	Caucasian	Frozen	1 mL	11	—	VYVGART IV infusion, scheduled every week CellCept 1500mg BID Prednisone 5mg QD Ibuprofen 400 mg BID PRN omeprazole 20mg QD	Myasthenia Gravis	United States	2026	—	—	—	—	—	—	—	—	—	196788; 196782; 196781; 196784; 196783; 196786; 196791; 196785; 196789; 196787; 196790	Plasma	Myasthenia Gravis	Myasthenia Gravis	Yes	seasonal (rarely)	32.55		Yes	Other	No			No	NO	No			Stored	In Stock	$495
Myasthenia Gravis Plasma	74321	115032	Female	46-60	African American	Frozen	1 mL	16	—	Prednisone/10mg/QD Munjaro 2.5 mg QW Rosuvastatin 5mg QD Olmesartan medoxomil 5 mg QD Low estrogen	Myasthenia Gravis	United States	2026	—	—	—	—	—	—	—	—	—	191935; 191950; 191949; 191948; 191947; 191946; 191945; 191944; 191943; 191942; 191941; 191940; 191939; 191938; 191937; 191936	Plasma	Myasthenia Gravis	Myasthenia Gravis	No		24.97		No		No			No	NO	Yes			Stored	In Stock	$495
Myasthenia Gravis Plasma	73388	117364	Female	61+	Caucasian	Frozen	1 mL	11	—	Mestinon/60mg/4 times daily Prednisone tapering dose IVIG one dose (yearly) Zetia for cholesterol	Myasthenia Gravis	United States	2026	—	—	—	—	—	—	—	—	—	187623; 187624; 187625; 187626; 187615; 187616; 187617; 187618; 187620; 187621; 187622	Plasma	Myasthenia Gravis	Myasthenia Gravis	Yes	penicilin	20.64		No		No			Yes	NO	Yes			Stored	In Stock	$495
Myasthenia Gravis Plasma	73628	112118	Male	46-60	Caucasian	Frozen	1 mL	11	—	Atorvastatin 40 mg for cholesterol QD Bilt-XR 240 mg blood pressure medication QD Omeprazole 20 mg QD Lisinopril 10 mg QD Baby aspirin 81 mg QD Allegra PRN	Myasthenia Gravis	United States	2026	—	—	—	—	—	—	—	—	—	188082; 188084; 188080; 188081; 188085; 188083; 188078; 188079; 188076; 188077; 188075	Plasma	Myasthenia Gravis	Myasthenia Gravis	Yes	Seasonal	33.72		No		No			Yes	NO	Yes			Stored	In Stock	$495
Myasthenia Gravis Plasma	73394	125040	Female	31-45	Caucasian	Frozen	1 mL	16	—	Rituximab Mestinon 120 mg TID Prednisone 20 mg QD Prozac 50mg QD Gabapentin 300mg TID Seroquel 100mg QD	Myasthenia Gravis	United States	2026	—	—	—	—	—	—	—	—	—	188130; 188129; 188144; 188143; 188142; 188141; 188140; 188139; 188138; 188137; 188136; 188135; 188134; 188133; 188132; 188131	Plasma	Myasthenia Gravis	Myasthenia Gravis	No		36.35		No										Stored	In Stock	$495
Myasthenia Gravis Plasma	73320	148998	Female	46-60	Caucasian	Frozen	1 mL	13	—	Hizentra Immune Globulin Subcutaneous Junel (birth control) low dose naltrexone 4.5mg QD T4 levothyroxine 220mcg QD T3 Liothyronine 48mcg QD History of IVIG	Myasthenia Gravis	United States	2026	—	—	—	—	—	—	—	—	—	186412; 186413; 186414; 186402; 186403; 186404; 186405; 186406; 186407; 186408; 186409; 186410; 186411	Plasma	Myasthenia Gravis	Myasthenia Gravis	No		24.21		Yes	Other	Yes-Currently Smokes	1	0.1	Yes	NO	Yes			Stored	In Stock	$495
Myasthenia Gravis Plasma	73188	110916	Female	61+	Caucasian	Frozen	1 mL	18	—	Ventolin HFA 90 mcg/act inhale 2 puffs PRN Glucosam HCL/MSM/Chondro SU A QD Calcium carbonate/vitamin d3 QD Lutein 20 mg, Ocuvite tab QD Probiotic blend QD Diltiazem 120 mg QD Levothyroxine 7.5 mcg per week Pyridostigmine bromide 60-240 mg PRN Furosemide 40 mg QD Elliquis 5 mg BID B-12 Vit Carvedilol BID Mestinon 50 mg 3 times per day	Myasthenia Gravis	United States	2026	—	—	—	—	—	—	—	—	—	185866; 185848; 185849; 185850; 185851; 185852; 185853; 185854; 185856; 185857; 185855; 185859; 185860; 185861; 185862; 185863; 185864; 185865	Plasma	Myasthenia Gravis	Myasthenia Gravis	Yes	mold, mildews, smoke, trazadone, cipro (exacerbates MG), no quinine based drugs, No statin drugs or magnesium, beta blockers, Tetracycline	38.1		No		Used to Smoke	10	1	Yes	NO	Yes			Stored	In Stock	$495
Myasthenia Gravis Plasma	73187	148938	Female	61+	Caucasian	Frozen	1 mL	15	—	Cellcept 1000mg BID Mestinon 120mg TID Effexor 150mg QD Other vitamins OTC Cannabis for sleep	Myasthenia Gravis	United States	2026	—	—	—	—	—	—	—	—	—	186728; 186727; 186726; 186725; 186724; 186723; 186722; 186721; 186720; 186719; 186718; 186732; 186731; 186730; 186729	Plasma	Myasthenia Gravis	Myasthenia Gravis	No		40.33		No		No			Yes	YES	Yes			Stored	In Stock	$495
Myasthenia Gravis Plasma	73205	113935	Female	31-45	Caucasian	Frozen	1 mL	12	—	Symbicort 12 grams – twice weekly Xolair 300 mg – auto-injections every 4 weeks Mestinon ER 180 mg – twice daily Mestinon IR 60 mg – 4 times per day as needed (PRN) Cellcept 500 mg – twice daily Adderall 30 mg – twice daily Viibryd 40 mg – once daily (QD) Hydrocortisone 20 mg – three times daily (TID) Hydroxyzine 100 mg – as needed (PRN) Pantoprazole 40 mg – once daily (QD) Valacyclovir 500 mg – twice daily Benadryl – as needed for itching or infusion reactions	Myasthenia Gravis	United States	2026	—	—	—	—	—	—	—	—	—	185412; 185413; 185414; 185415; 185416; 185417; 185406; 185407; 185408; 185409; 185410; 185411	Plasma	Myasthenia Gravis	Myasthenia Gravis	Yes	Bactrim	19.47		No		No			No	NO	Yes			Stored	In Stock	$495
Myasthenia Gravis Plasma	66204	116873	Female	61+	Caucasian	Frozen	1 mL	11	—	Mestinon/60mg/4 times/day - PRN Prednisone/20mg/QD Alendronate 70mg once per week Vitamin B12 Vitamin d, Tums PRN Baby Aspirin QD Cellcept -, Apr 28th	Myasthenia Gravis	United States	2025	—	—	—	—	—	—	—	—	—	146188; 146184; 146185; 146186; 146187; 146178; 146179; 146180; 146181; 146182; 146183	Plasma	Myasthenia Gravis	Myasthenia Gravis	No		30.54		No		No			No	NO	Yes			Stored	In Stock	$495

Showing 1–23 of 23 lots

Results per page

About Myasthenia Gravis Plasma

Myasthenia Gravis Plasma for Autoimmune Neuromuscular Junction Research

Myasthenia Gravis Plasma is collected from IRB-consented donors clinically diagnosed with myasthenia gravis (MG) and processed within one day of collection to preserve autoantibodies, complement proteins, cytokines, and other labile analytes. MG is an antibody-mediated autoimmune disease of the neuromuscular junction: pathogenic IgG autoantibodies against the postsynaptic acetylcholine receptor (AChR) or muscle-specific kinase (MuSK) impair neuromuscular transmission, producing fatigable weakness.

Disease Biology and Why Plasma

AChR autoantibodies are present in the majority of generalised MG donors and act through complement-mediated damage to the postsynaptic membrane, receptor cross-linking and internalisation, and direct blockade of acetylcholine binding.
MuSK autoantibodies define a distinct, predominantly IgG4 subgroup that disrupts agrin-LRP4-MuSK signalling and postsynaptic AChR clustering rather than acting through complement.
Complement activation is central to AChR-positive disease and is the target of approved therapeutics; plasma preserves complement components and activation products for pathway analysis.
Seronegative and low-affinity antibody donors support cell-based assay development and discovery of additional autoantigens such as LRP4 and agrin.
IgG-directed therapeutics: FcRn antagonists and complement inhibitors are assessed through circulating total IgG and antibody titre, both plasma-appropriate readouts.
Plasma is acellular and is the correct matrix for autoantibody titration, complement profiling, cytokine multiplexing, proteomics, and metabolomics. For cellular assays, see the PBMC and leukopak products below.

Donor Stratification Available

Serostatus: AChR-positive, MuSK-positive, or seronegative
Clinical subtype: ocular versus generalised MG
Thymic pathology: thymoma-associated, thymic hyperplasia, or post-thymectomy
Age at onset: early-onset versus late-onset disease
Treatment status: acetylcholinesterase inhibitors, corticosteroids, non-steroidal immunosuppressants, rituximab, complement inhibitors, FcRn antagonists, IVIg or plasma exchange, or treatment-naive
Disease activity: stable, exacerbation, or history of myasthenic crisis
Matched healthy controls available

Product Features

Research Use Only (RUO)
Plasma collected from clinically confirmed MG donors
Processed within one day of collection
IRB-approved protocols and informed consent
Custom aliquot volumes available upon request

De-identified Donor Data

Verified MG diagnosis
Serostatus (AChR, MuSK) where available
Demographic data: age, sex assigned at birth, race/ethnicity
Donor-reported medications, allergies, and comorbidities
Additional myasthenia gravis-specific metadata available

Applications

AChR and MuSK autoantibody detection, titration, and isotype analysis
Radioimmunoassay, ELISA, and cell-based assay development and validation
Complement activation and complement inhibitor pharmacodynamic research
FcRn antagonist and IgG-lowering therapeutic research
Novel autoantigen discovery in seronegative donors
Cytokine and inflammation profiling
Proteomic and metabolomic biomarker discovery
Treatment response and disease activity biomarker studies

Other Myasthenia Gravis Specimen Types

MG donor material is also available as Myasthenia Gravis Serum, Myasthenia Gravis PBMC, Myasthenia Gravis Whole Blood, Myasthenia Gravis Leukopak, and Myasthenia Gravis Bulk Plasma for larger-volume requirements. Subtype-specific plasma is available as AChR+ Myasthenia Gravis Plasma, Ocular Myasthenia Gravis Plasma, Generalized Myasthenia Gravis Plasma, and Seronegative Myasthenia Gravis Plasma.

Compliance and Quality Assurance

IRB-approved and HIPAA-compliant protocols
Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
Documentation support available for regulatory review

Ordering & Customization

Myasthenia gravis plasma is available in standard and custom volumes. For pricing, international orders, or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations. For the full specimen range, see our human plasma collection.

Applications

Immunology and translational research
Biomarker discovery and validation
Drug screening and assay development
Vaccine and infectious disease research

Product Features

Research Use Only (RUO), Plasma
Sourced from screened, consented donors
Processed under validated SOPs
QC tested for purity, viability, and sterility
Processed within 24 hours of collection
IRB-approved protocols with electronic informed consent

Donor Metadata

Verified diagnosis and clinical history
Demographic data: age, sex assigned at birth, race/ethnicity
Medication and treatment background when available

Compliance and Quality Assurance

IRB-approved collections and standardized procedures
21 CFR Part 11-compliant e-consent system
HIPAA-compliant data management

Ordering & Customization

Human Plasma are available in customizable aliquot sizes. For international orders or documentation needs, please contact learnmore@sanguinebio.com to confirm requirements and availability. We also work with multiple ordering platforms and distributors, learn more here.

Protocols & Documentation

Plasma Isolation

Protocol for plasma separation from anticoagulated whole blood, including processing, storage, and traceability requirements.

Download
Informed Consent Form (ICF)

Available upon request — confirms donor consent for research use and downstream commercialization.

Plasma

Where can I find your complete catalog?

You can find our full product catalog here.

How long can samples be stored?

Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.

What customization options are available?

Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.

Do you offer prospective collections?

Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.

What is the turnaround time for custom collections?

Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.

Do you have samples in stock?

YES - we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.

What does unique donor mean?

Each sample from a different individual - Unique donor means each sample comes from a different person, ensuring biological diversity in your study.

Are samples collected under IRB-approved protocols?

YES - "IRB-approved collection protocols" and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.

Frequently Asked Questions

Pair with a Healthy Control

Match your Myasthenia Gravis Plasma with normal donor samples for comparison

Healthy Plasma

207 In Stock Screened normal donors · Frozen · Starting at $132 View Inventory

Need a custom Plasma cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information

Myasthenia Gravis Plasma

All filters

About Myasthenia Gravis Plasma

Myasthenia Gravis Plasma for Autoimmune Neuromuscular Junction Research

Disease Biology and Why Plasma

Donor Stratification Available

Product Features

De-identified Donor Data

Applications

Other Myasthenia Gravis Specimen Types

Compliance and Quality Assurance

Ordering & Customization

Applications

Product Features

Donor Metadata

Compliance and Quality Assurance

Ordering & Customization

Protocols & Documentation

Plasma Isolation

Informed Consent Form (ICF)

Plasma

Frequently Asked Questions

Pair with a Healthy Control

Healthy Plasma

Need a custom Plasma cohort?

Corporate Headquarters

Kitting Facility

Sanguine Apheresis Center LA

How would you like to check out?

Sign in

Sign in to get your quote

Sign in to your account

New to Sanguine?

Myasthenia Gravis Plasma

All filters

About Myasthenia Gravis Plasma

Myasthenia Gravis Plasma for Autoimmune Neuromuscular Junction Research

Disease Biology and Why Plasma

Donor Stratification Available

Product Features

De-identified Donor Data

Applications

Other Myasthenia Gravis Specimen Types

Compliance and Quality Assurance

Ordering & Customization

Applications

Product Features

Donor Metadata

Compliance and Quality Assurance

Ordering & Customization

Protocols & Documentation

Plasma Isolation

Informed Consent Form (ICF)

Plasma

Frequently Asked Questions

Ask a Question

Pair with a Healthy Control

Healthy Plasma

Related Products

Need a custom Plasma cohort?

Corporate Headquarters

Kitting Facility

Sanguine Apheresis Center LA

Schedule a Meeting